Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH.

作者: Barry L. Carter

DOI: 10.18553/JMCP.2004.10.S5-A.S18

关键词:

摘要: BACKGROUND: The new guidelines issued by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) emphasize that aggressive blood pressure (BP) control is essential to reducing morbidity mortality. Additionally, American Diabetes Association (ADA) World Health Organization-International Society Hypertension (WHO-ISH) critical need for lowering BP levels. Achieving goals a challenge patients their physicians, most are not at goal. Poor even more with diabetes chronic kidney disease since lower. strategies levels include patient lifestyle changes, adherence therapy, regular monitoring OBJECTIVE: To summarize antihypertension recommended WHO-ISH, JNC 7, ADA, in African Americans Working Group (HAAW Group) International Blacks evaluate pharmacist’s collaborative role management hypertension examining results programs designed pharmacist counseling. METHODS: relevant literature was evaluated reviewed. Emphasis placed improve control. RESULTS: Results from several studies showed positive effects collaboration. A program provided academic detailing physicians 5 Veterans Affairs facilities resulted significant increases receiving β-blocker therapy or thiazide diuretics angiotensin-converting enzyme inhibitor angiotensin receptor blocker therapy. Another study which hypertensive received clinical services pharmacists improvement patients’ knowledge its adherence, also increase number whose stayed normal range. 6-month, controlled, single-blind, parallel-group 51 improvements control, quality life, overall satisfaction group treatment through primary care team included pharmacists. Among Administration medical center, suggested intervention improved documentation drug estimated compliance. effectiveness comanagement 197 physician-pharmacist collaboration using an evidence-based, systematic approach significantly larger achieved than group. CONCLUSIONS: expanded evaluating, monitoring, treating can result established guidelines. As members interdisciplinary health teams, should utilize 7 scientific evidence consult about medications, design effective formularies, collaborate evaluating comanaging hypertension.

参考文章(14)
Reginald H. Smithwick, Hypertensive vascular disease Journal of Chronic Diseases. ,vol. 1, pp. 477- 496 ,(1955) , 10.1016/0021-9681(55)90061-8
D. J. Weatherall, D. A. Warrell, J. G. G. Ledingham, Oxford textbook of medicine ,(1996)
Elizabeth Chrischilles, Debra J. Barnette, Barry L. Carter, Gordon J. Mazzotti, Ziad J. Asali, Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. ,vol. 17, pp. 1274- 1285 ,(1997) , 10.1002/J.1875-9114.1997.TB03092.X
T. Farley, Current Diagnosis 9 Journal of The American Board of Family Practice. ,vol. 11, pp. 83- 84 ,(1998) , 10.3122/15572625-11-1-83B
Chester A. Bond, Sustained Improvement in Drug Documentation, Compliance, and Disease Control Archives of Internal Medicine. ,vol. 144, pp. 1159- 1162 ,(1984) , 10.1001/ARCHINTE.1984.00350180071011
Barry L. Carter, Alan J. Zillich, William J. Elliott, How Pharmacists Can Assist Physicians With Controlling Blood Pressure Journal of Clinical Hypertension. ,vol. 5, pp. 31- 37 ,(2003) , 10.1111/J.1524-6175.2003.01460.X
JAMES M. McKENNEY, JUDITH M. SLINING, H. RICHARD HENDERSON, DOUGLAS DEVINS, MARTIN BARR, The effect of clinical pharmacy services on patients with essential hypertension. Circulation. ,vol. 48, pp. 1104- 1111 ,(1973) , 10.1161/01.CIR.48.5.1104
Roberta Monson, Role of the Clinical Pharmacist in Improving Drug Therapy Archives of Internal Medicine. ,vol. 141, pp. 1441- 1444 ,(1981) , 10.1001/ARCHINTE.1981.00340120049011
David Siegel, Julio Lopez, Joy Meier, Mary K Goldstein, Samuel Lee, Bradley J Brazill, Mazen S Matalka, Academic detailing to improve antihypertensive prescribing patterns American Journal of Hypertension. ,vol. 16, pp. 508- 511 ,(2003) , 10.1016/S0895-7061(03)00060-8